RU2001126527A - MEANS AND METHOD OF TREATMENT OR PREVENTION OF ARTERIOSCLEROSIS - Google Patents
MEANS AND METHOD OF TREATMENT OR PREVENTION OF ARTERIOSCLEROSISInfo
- Publication number
- RU2001126527A RU2001126527A RU2001126527/14A RU2001126527A RU2001126527A RU 2001126527 A RU2001126527 A RU 2001126527A RU 2001126527/14 A RU2001126527/14 A RU 2001126527/14A RU 2001126527 A RU2001126527 A RU 2001126527A RU 2001126527 A RU2001126527 A RU 2001126527A
- Authority
- RU
- Russia
- Prior art keywords
- arteriosclerosis
- treatment
- prevention
- drug
- candesartan
- Prior art date
Links
- 206010003210 Arteriosclerosis Diseases 0.000 title claims 6
- 230000002265 prevention Effects 0.000 title claims 3
- 239000003814 drug Substances 0.000 claims 7
- UQGKUQLKSCSZGY-UHFFFAOYSA-N (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate Chemical compound C=1C=C(C=2C(=CC=CC=2)C2=NNN=N2)C=CC=1CN1C(CCC)=NC(C(C)(C)O)=C1C(=O)OCC=1OC(=O)OC=1C UQGKUQLKSCSZGY-UHFFFAOYSA-N 0.000 claims 6
- 229960001199 Olmesartan medoxomil Drugs 0.000 claims 6
- 229940079593 drugs Drugs 0.000 claims 6
- 239000002083 C09CA01 - Losartan Substances 0.000 claims 3
- 239000002053 C09CA06 - Candesartan Substances 0.000 claims 3
- SGZAIDDFHDDFJU-UHFFFAOYSA-N Candesartan Chemical compound CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SGZAIDDFHDDFJU-UHFFFAOYSA-N 0.000 claims 3
- 229960004773 Losartan Drugs 0.000 claims 3
- KJJZZJSZUJXYEA-UHFFFAOYSA-N Losartan Chemical compound CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C=2[N]N=NN=2)C=C1 KJJZZJSZUJXYEA-UHFFFAOYSA-N 0.000 claims 3
- 229960000932 candesartan Drugs 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000069 prophylaxis Effects 0.000 claims 1
Claims (6)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8/184368 | 1996-07-15 | ||
JP18436896 | 1996-07-15 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU99103215/14A Division RU2183128C2 (en) | 1996-07-15 | 1997-07-11 | Pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001126527A true RU2001126527A (en) | 2003-06-27 |
RU2220723C2 RU2220723C2 (en) | 2004-01-10 |
Family
ID=16152008
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001126527/14A RU2220723C2 (en) | 1996-07-15 | 1997-07-11 | Agent and method for treatment or prophylaxis of arteriosclerosis |
RU99103215/14A RU2183128C2 (en) | 1996-07-15 | 1997-07-11 | Pharmaceutical composition |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU99103215/14A RU2183128C2 (en) | 1996-07-15 | 1997-07-11 | Pharmaceutical composition |
Country Status (19)
Country | Link |
---|---|
US (1) | US6610682B2 (en) |
EP (2) | EP1175902B1 (en) |
KR (1) | KR100540618B1 (en) |
CN (2) | CN1221259C (en) |
AT (2) | ATE306921T1 (en) |
AU (1) | AU714618B2 (en) |
CA (1) | CA2261040C (en) |
CZ (2) | CZ299162B6 (en) |
DE (2) | DE69731840T2 (en) |
DK (2) | DK1175902T3 (en) |
ES (2) | ES2250283T3 (en) |
HK (1) | HK1020260A1 (en) |
HU (2) | HU227399B1 (en) |
IL (2) | IL128059A (en) |
NO (2) | NO322314B1 (en) |
NZ (1) | NZ333723A (en) |
PT (1) | PT930076E (en) |
RU (2) | RU2220723C2 (en) |
WO (1) | WO1998002183A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001047509A2 (en) * | 1999-12-24 | 2001-07-05 | Smithkline Beecham P.L.C. | Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions |
DE19962924A1 (en) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituted oxazolidinones and their use |
MXPA02010090A (en) * | 2000-04-12 | 2003-02-12 | Novartis Ag | Combination of organic compounds. |
DE10129725A1 (en) | 2001-06-20 | 2003-01-02 | Bayer Ag | Combination therapy of substituted oxazolidinones |
US20040219208A1 (en) * | 2001-08-03 | 2004-11-04 | Ryu Kawamura | Sustained-release medicines |
DE10300111A1 (en) | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide |
EA009983B1 (en) * | 2003-01-31 | 2008-04-28 | Дайити Санкио Компани, Лимитед | Medicine for prevention of and treatment for arteriosclerosis and hypertension |
DE10355461A1 (en) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases |
EP1750862B1 (en) * | 2004-06-04 | 2011-01-05 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical composition containing irbesartan |
EP1685841A1 (en) | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention and treatment of thromboembolic disorders |
RU2441653C2 (en) * | 2005-05-31 | 2012-02-10 | Милан Лэборетериз, Инк. | Compositions containing nebivolol |
WO2007001066A1 (en) * | 2005-06-27 | 2007-01-04 | Daiichi Sankyo Company, Limited | Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker |
DE102005045518A1 (en) | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa |
US8188270B2 (en) | 2005-10-04 | 2012-05-29 | Bayer Schering Pharma Aktiengesellschaft | Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
DE102005047561A1 (en) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance |
TWI399223B (en) * | 2006-09-15 | 2013-06-21 | Daiichi Sankyo Co Ltd | Solid dosage form of olmesartan medoxomil and amlodipine |
US20090076104A1 (en) * | 2007-09-17 | 2009-03-19 | Protia, Llc | Deuterium-enriched losartan |
RU2011124948A (en) * | 2008-11-19 | 2012-12-27 | Мериал Лимитед | COMPOSITIONS, INCLUDING 1-ARILPIRAZOLE ON YOURSELF OR IN COMBINATION WITH FORMAMIDINE, FOR THE TREATMENT OF PARASITIC INFECTIONS |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
CN107617107A (en) * | 2017-09-18 | 2018-01-23 | 浙江大学 | A kind of anti-scar preparation of compound Angiotensin-Converting class |
CN107648611A (en) * | 2017-09-18 | 2018-02-02 | 浙江大学 | The anti-cicatrix externally used preparation of compound Angiotensin-Converting class |
CN110075304B (en) * | 2019-05-29 | 2020-02-11 | 四川大学华西医院 | Pharmaceutical composition for treating osteoarthritis and application thereof |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5231080A (en) | 1985-10-15 | 1993-07-27 | Hoechst Aktiengesellschaft | Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease |
DE3536687A1 (en) * | 1985-10-15 | 1987-04-16 | Hoechst Ag | METHOD FOR TREATING ATHEROSCLEROSIS, THROMBOSIS AND PERIPHERAL VESSEL DISEASE |
US5223522A (en) * | 1988-03-08 | 1993-06-29 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
WO1989008651A1 (en) * | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
CA2016467A1 (en) * | 1989-06-05 | 1990-12-05 | Martin Eisman | Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor |
DE3925759A1 (en) * | 1989-08-03 | 1991-02-07 | Thera Patent Verwaltungs Gmbh | USE OF ACE INHIBITORS FOR ATHEROSKLEROSEPROPHYLAXE |
US5061694A (en) * | 1989-10-23 | 1991-10-29 | E. R. Squibb & Sons, Inc. | Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor |
CA2026686A1 (en) | 1989-10-30 | 1991-05-01 | Werner Tschollar | Method for preventing onset of type ii diabetes employing an ace inhibitor |
GB2241890A (en) | 1990-03-12 | 1991-09-18 | Squibb & Sons Inc | Preventing onset of or treating protein catabolism using an ace inhibitor |
US5298497A (en) | 1990-05-15 | 1994-03-29 | E. R. Squibb & Sons, Inc. | Method for preventing onset of hypertension employing a cholesterol lowering drug |
IS1756B (en) * | 1991-02-21 | 2000-12-28 | Sankyo Company Limited | Analogue method for the preparation of 1-biphenylmethylimidazole derivatives |
US5616599A (en) | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
US5668117A (en) | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
CA2118706A1 (en) * | 1992-07-13 | 1994-01-20 | Saizo Shibata | Novel thiazolidinedione compounds and use thereof |
JPH0741423A (en) | 1993-02-24 | 1995-02-10 | Sankyo Co Ltd | Therapeutic agent for arteriosclerosis |
AU6114794A (en) * | 1993-02-24 | 1994-09-14 | Sankyo Company Limited | Arteriosclerosis remedy |
NO303782B1 (en) * | 1994-03-23 | 1998-08-31 | Sankyo Co | Thiazolidine and oxazolidine derivatives and pharmaceutical preparations containing them, as well as their use in the manufacture of medicaments |
CA2186606A1 (en) * | 1994-03-29 | 1995-10-05 | Edward B. Nelson | Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles |
TWI238064B (en) | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
CN1215338A (en) | 1996-04-05 | 1999-04-28 | 武田药品工业株式会社 | Pharmaceutical combination containing a compound having angiotensin II and antagonisti activity |
-
1997
- 1997-07-11 DK DK01124669T patent/DK1175902T3/en active
- 1997-07-11 EP EP01124669A patent/EP1175902B1/en not_active Expired - Lifetime
- 1997-07-11 HU HU0600501A patent/HU227399B1/en unknown
- 1997-07-11 DK DK97930762T patent/DK0930076T3/en active
- 1997-07-11 RU RU2001126527/14A patent/RU2220723C2/en active
- 1997-07-11 DE DE69731840T patent/DE69731840T2/en not_active Expired - Lifetime
- 1997-07-11 AT AT01124669T patent/ATE306921T1/en active
- 1997-07-11 PT PT97930762T patent/PT930076E/en unknown
- 1997-07-11 HU HU9903166A patent/HU225415B1/en unknown
- 1997-07-11 CN CNB03136392XA patent/CN1221259C/en not_active Expired - Lifetime
- 1997-07-11 CZ CZ0010299A patent/CZ299162B6/en not_active IP Right Cessation
- 1997-07-11 ES ES01124669T patent/ES2250283T3/en not_active Expired - Lifetime
- 1997-07-11 DE DE69734405T patent/DE69734405T2/en not_active Expired - Lifetime
- 1997-07-11 CA CA002261040A patent/CA2261040C/en not_active Expired - Lifetime
- 1997-07-11 NZ NZ333723A patent/NZ333723A/en not_active IP Right Cessation
- 1997-07-11 WO PCT/JP1997/002407 patent/WO1998002183A1/en active IP Right Grant
- 1997-07-11 KR KR1019997000222A patent/KR100540618B1/en not_active IP Right Cessation
- 1997-07-11 IL IL12805997A patent/IL128059A/en not_active IP Right Cessation
- 1997-07-11 EP EP97930762A patent/EP0930076B1/en not_active Expired - Lifetime
- 1997-07-11 CN CNB971979391A patent/CN1155409C/en not_active Expired - Lifetime
- 1997-07-11 AT AT97930762T patent/ATE283704T1/en active
- 1997-07-11 AU AU34595/97A patent/AU714618B2/en not_active Expired
- 1997-07-11 CZ CZ20080174A patent/CZ300089B6/en not_active IP Right Cessation
- 1997-07-11 RU RU99103215/14A patent/RU2183128C2/en active
- 1997-07-11 ES ES97930762T patent/ES2232873T3/en not_active Expired - Lifetime
-
1999
- 1999-01-14 NO NO19990166A patent/NO322314B1/en not_active IP Right Cessation
- 1999-11-22 HK HK99105398A patent/HK1020260A1/en not_active IP Right Cessation
-
2001
- 2001-08-21 US US09/933,922 patent/US6610682B2/en not_active Expired - Lifetime
- 2001-10-04 IL IL145758A patent/IL145758A/en not_active IP Right Cessation
-
2005
- 2005-12-16 NO NO20056021A patent/NO334217B1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2001126527A (en) | MEANS AND METHOD OF TREATMENT OR PREVENTION OF ARTERIOSCLEROSIS | |
CA2289717A1 (en) | Novel therapy for constipation | |
UA49869C2 (en) | NAPHTHYL-SUBSTITUTED BENZIMIDAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, METHOD FOR TREATMENT (VARIANTS), METHOD FOR INHIBITING HUMAN FACTOR Xa OR IIa | |
HK1008294A1 (en) | (2-4-Disulfophenyl) n-tertiary butyl nitrone its salts and their use as pharmaceutical radical trapping agents | |
EP1029540A3 (en) | Use of droloxifene for the treatment of cardiovascular diseases | |
RU2220723C2 (en) | Agent and method for treatment or prophylaxis of arteriosclerosis | |
EP1688143A3 (en) | Niacin-containing substained-release tablets and kits | |
CA2174338A1 (en) | Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound | |
IS4394A (en) | Therapeutic compounds, pharmaceutically acceptable salts and compositions containing the compounds, together with their use | |
PL323490A1 (en) | Tetralinic compounds exibiting acitity against multgiple-drug refractoriness | |
CA2150184A1 (en) | Pharmaceutical composition for the treatment of inflammatory bowel diseases | |
CA2343732A1 (en) | Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto | |
CA2283255A1 (en) | Use of r-nsaid's for the prevention of alzheimer's disease | |
RU93047023A (en) | ANIMOTENZINE-11 IMIDAZOLE ANTAGONISTS DERIVATIVES, THEIR PRODUCTION AND THERAPEUTIC USE | |
ES2093357T3 (en) | ALOPECIA TREATMENT METHOD. | |
AU1656997A (en) | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer | |
NZ268110A (en) | Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage | |
CA2235951A1 (en) | Novel uses of mammalian ctla-8 and related reagents | |
FR2714603B1 (en) | Dermatological composition and its use for the preparation of a medicament. | |
HUP9802736A3 (en) | Use of 1,4-dihydropyridine derivatives for the preparation of medicament for the prevention and therapy of atherosclerotic degradation in the arterial walls | |
IL118833A (en) | Sertraline for use as a medicament in the treatment of post-myocardial infarction patients | |
CA2269031A1 (en) | Treatment of urinary incontinence and compositions for use therein | |
NO960347L (en) | Use of benzydamide in the treatment of pathological conditions caused by TNF | |
RU96119673A (en) | METHOD FOR TREATING PAIN SYNDROME | |
CA2248753A1 (en) | Use of olanzapine for treating excessive aggression |